Truist Financial
FBT icon

Truist Financial’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Truist Financial’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.9M Sell
54,147
-1,081
-2% -$224K 0.01% 588
2025
Q4 		$11.4M Buy
55,228
+9,897
+22% +$1.98M 0.02% 569
2025
Q3 		$8.13M Buy
45,331
+97
+0.2% +$16.5K 0.01% 686
2025
Q2 		$7.3M Buy
45,234
+5,136
+13% +$818K 0.01% 694
2025
Q1 		$6.82M Buy
40,098
+609
+2% +$106K 0.01% 697
2024
Q4 		$6.56M Sell
39,489
-5,353
-12% -$915K 0.01% 719
2024
Q3 		$7.71M Buy
44,842
+272
+0.6% +$45K 0.01% 672
2024
Q2 		$6.86M Buy
44,570
+2,320
+5% +$348K 0.01% 736
2024
Q1 		$6.5M Buy
42,250
+2,515
+6% +$383K 0.01% 780
2023
Q4 		$6.28M Buy
39,735
+6,782
+21% +$974K 0.01% 786
2023
Q3 		$4.82M Buy
32,953
+1,492
+5% +$227K 0.01% 854
2023
Q2 		$4.82M Buy
31,461
+5,977
+23% +$932K 0.01% 847
2023
Q1 		$3.95M Sell
25,484
-8,536
-25% -$1.34M 0.01% 922
2022
Q4 		$5.24M Sell
34,020
-9,409
-22% -$1.39M 0.01% 804
2022
Q3 		$5.73M Buy
43,429
+17,791
+69% +$2.5M 0.01% 727
2022
Q2 		$3.48M Buy
25,638
+1,069
+4% +$147K 0.01% 948
2022
Q1 		$3.66M Sell
24,569
-281
-1% -$41.6K 0.01% 1005
2021
Q4 		$4.03M Sell
24,850
-17,445
-41% -$2.82M 0.01% 971
2021
Q3 		$7.02M Buy
42,295
+12,853
+44% +$2.2M 0.01% 761
2021
Q2 		$5.08M Sell
29,442
-5,903
-17% -$975K 0.01% 876
2021
Q1 		$5.67M Sell
35,345
-246
-0.7% -$42.1K 0.01% 800
2020
Q4 		$5.98M Sell
35,591
-4,530
-11% -$735K 0.01% 754
2020
Q3 		$6.31M Sell
40,121
-9,290
-19% -$1.52M 0.01% 685
2020
Q2 		$8.29M Buy
49,411
+7,270
+17% +$1.14M 0.02% 577
2020
Q1 		$5.53M Buy
42,141
+12,607
+43% +$1.8M 0.01% 647
2019
Q4 		$4.39M Buy
+29,534
New +$4.06M 0.01% 795

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Truist Financial's FBT Position: Q1 2026 in Review

Truist Financial reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 2% in Q1 2026, selling an estimated $224K and leaving 54,147 shares worth $10.9M. The position accounts for 0.01% of the portfolio, ranked #588.

Truist Financial first reported a position in FBT in Q4 2019 and has held it in 26 quarters since. The position peaked at $11.4M in Q4 2025. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Truist Financial held 54,147 shares of First Trust NYSE Arca Biotechnology Index Fund worth $10.9M as of Q1 2026.
  • Truist Financial sold 1,081 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $224K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Truist Financial's portfolio in Q1 2026, its #588 holding.
  • Truist Financial first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2019 and has held it in 26 quarters since.
  • Truist Financial's First Trust NYSE Arca Biotechnology Index Fund position peaked at $11.4M in Q4 2025.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.